Helios

Packaging: 10 mL bottle

Composition: 40 mcg/mL of Clenbuterol + 20 mcg/mL of Yohimbine

Description:
Helios is a combined solution of Clenbuterol (beta-2 agonist) and Yohimbine (alpha-2 antagonist), developed for subcutaneous application in areas with greater fat accumulation. It is mainly used for localized fat burning, muscle definition and improved vascularization.

Helios Profile

• Type: Localized thermogenic (subcutaneous injection)

• Active ingredients: Clenbuterol (systemic and local action) + Yohimbine (localized action)

• Half-life:

  • Clenbuterol: 36 hours

  • Yohimbine: 1-2 hours

• Liver toxicity: Nil

Effects

• Stimulates the burning of stubborn fat (abdomen, flanks, etc.)

• Improves local definition and vascularization

• Increases energy, focus and physical performance

• Powerful synergistic effect with fasted cardio

Dosage and Usage

• Usual dose: 0.5 to 1 mL per application, 1-2x daily

• Route: Subcutaneous (local injection with fine needle)

• Ideal time: On an empty stomach before aerobic activity

• Cycle: 2 to 4 weeks followed by a break

Side Effects

• Tremors, sweating, tachycardia

• Anxiety, nervousness, insomnia

• Irritation at the application site (rare)